81 FR 90054 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 81, Issue 239 (December 13, 2016)
Federal Motor Carrier Safety Administration
Federal Register Volume 81, Issue 239 (December 13, 2016)
| Page Range | 90054-90060 | |
| FR Document | 2016-29825 |
[Federal Register Volume 81, Number 239 (Tuesday, December 13, 2016)] [Notices] [Pages 90054-90060] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-29825] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2016-0380] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA). ACTION: Notice of applications for exemptions; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 43 individuals for exemption from the prohibition against persons with insulin-treated diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before January 12, 2017. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2016-0380 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE., Washington, [[Page 90055]] DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket numbers for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. The Federal Docket Management System (FDMS) is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self- addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the Federal Motor Carrier Safety Regulations for a 2-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the 2-year period. The 43 individuals listed in this notice have recently requested such an exemption from the diabetes prohibition in 49 CFR 391.41(b) (3), which applies to drivers of CMVs in interstate commerce. Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. II. Qualifications of Applicants Tony E. Allen Mr. Allen, 57, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Allen understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Allen meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New York. Habib Awol Mr. Awol, 46, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Awol understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Awol meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Maryland. Michael J. Beatty Mr. Beatty, 57, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Beatty understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Beatty meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Pennsylvania. Troy J. Bolduc Mr. Bolduc, 23, has had ITDM since 2006. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bolduc understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bolduc meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Hampshire. James W. Britt Mr. Britt, 57, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Britt understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Britt meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from North Carolina. Gilberto A. Cortez Mr. Cortez, 65, has had ITDM since 2008. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in [[Page 90056]] the last 5 years. His endocrinologist certifies that Mr. Cortez understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cortez meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from North Carolina. Lawrence Davidson Mr. Davidson, 68, has had ITDM since 2010. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Davidson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Davidson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from New Mexico. Julio Duval-Medina Mr. Duval-Medina, 66, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Duval-Medina understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Duval-Medina meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New Jersey. Darlene R. Errichetto Ms. Errichetto, 53, has had ITDM since 2011. Her endocrinologist examined her in 2016 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Errichetto understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Errichetto meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her ophthalmologist examined her in 2016 and certified that she has stable nonproliferative diabetic retinopathy. She holds a Class B CDL from Massachusetts. Michael D. Ezell Mr. Ezell, 31, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Ezell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Ezell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Georgia. Thomas E. Fey Mr. Fey, 50, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Fey understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Fey meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New York. Arthur Freeman, Jr. Mr. Freeman, 66, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Freeman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Freeman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Florida. Gregory L. Grieves Mr. Grieves, 34, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Grieves understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Grieves meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Ohio. Gregory S. Gustafson Mr. Gustafson, 48, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Gustafson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gustafson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class C CDL from Tennessee. [[Page 90057]] Becky S. Hanley Ms. Hanley, 41, has had ITDM since 2012. Her endocrinologist examined her in 2016 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Hanley understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Hanley meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her optometrist examined her in 2016 and certified that she does not have diabetic retinopathy. She holds an operator's license from Nebraska. Frederick M. Harris Mr. Harris, 46, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Harris understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Harris meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from California. Brian W. Hinzman Mr. Hinzman, 47, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hinzman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hinzman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from South Dakota. Emory S. Hudson, Jr. Mr. Hudson, 47, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hudson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hudson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Georgia. Paul E. Iacobacci Mr. Iacobacci, 57, has had ITDM since 2012. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Iacobacci understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Iacobacci meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Massachusetts. David A. Kutcher Mr. Kutcher, 60, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Kutcher understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kutcher meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Ohio. Tony M. Lawrence Mr. Lawrence, 51, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Lawrence understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lawrence meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class B CDL from New York. Ronald E. Lockridge Mr. Lockridge, 49, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Lockridge understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lockridge meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Indiana. Eileen E. Manning Ms. Manning, 65, has had ITDM since 2015. Her endocrinologist examined her in 2016 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Manning understands diabetes management and monitoring has stable [[Page 90058]] control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Manning meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her optometrist examined her in 2016 and certified that she does not have diabetic retinopathy. She holds a Class B CDL from Wisconsin. Warren G. Marlow, Jr. Mr. Marlow, 58, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Marlow understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Marlow meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Indiana. Edward S. Marshall Mr. Marshall, 51, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Marshall understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Marshall meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Maine. Arthur D. McFadden, Sr. Mr. McFadden, 72, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. McFadden understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. McFadden meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. Jeffrey S. Moyer Mr. Moyer, 60, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Moyer understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Moyer meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Washington. Joseph M. Mraw Mr. Mraw, 60, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Mraw understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Mraw meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Richard K. E. Nelson Mr. Nelson, 23, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Nelson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Nelson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Virginia. Charles W. Norris Mr. Norris, 65, has had ITDM since 1998. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Norris understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Norris meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Massachusetts. Kevin W. Pochopin Mr. Pochopin, 27, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Pochopin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Pochopin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New York. Antonia S. Romao Mr. Romao, 51, has had ITDM since 2001. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the [[Page 90059]] assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Romao understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Romao meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Massachusetts. Paul Ross, Jr. Mr. Ross, 54, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Ross understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Ross meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Georgia. Matthew G. Russo, Jr. Mr. Russo, 59, has had ITDM since 2012. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Russo understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Russo meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Cole J. Schoenneman Mr. Schoenneman, 23, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Schoenneman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Schoenneman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from California. Charles W. Scott, Jr. Mr. Scott, 53, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Scott understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Scott meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Maryland. Mickey J. Self Mr. Self, 41, has had ITDM since 1986. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Self understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Self meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Georgia. Jeffrey E. Sobczak Mr. Sobczak, 54, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Sobczak understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Sobczak meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wisconsin. Michael D. Strickland Mr. Strickland, 58, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Strickland understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Strickland meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Illinois. Vince D. Venezia Mr. Venezia, 40, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Venezia understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Venezia meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist [[Page 90060]] examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Jared M. Wabeke Mr. Wabeke, 30, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Wabeke understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Wabeke meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a CDL from Michigan. Marcus D. Wade Mr. Wade, 22, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Wade understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Wade meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Illinois. Tanner R. Walsh Mr. Walsh, 22, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Walsh understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Walsh meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Minnesota. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the date section of the notice. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441).\1\ The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). --------------------------------------------------------------------------- \1\ Section 4129(a) refers to the 2003 notice as a ``final rule.'' However, the 2003 notice did not issue a ``final rule'' but did establish the procedures and standards for issuing exemptions for drivers with ITDM. --------------------------------------------------------------------------- Section 4129 requires: (1) Elimination of the requirement for 3 years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the 3-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C.. 31136(e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003 notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003 notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2016-0380 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. FMCSA may issue a final determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2016-0380 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. Issued on: December 2, 2016. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2016-29825 Filed 12-12-16; 8:45 am] BILLING CODE 4910-EX-P
![90054 Federal Register / Vol. 81, No. 239 / Tuesday, December 13, 2016 / Notices
Robert V. Sloan (NC) Jerry P. Lindesmith (OK) FMCSA–2009–0011; FMCSA–2011–
Steven L. Valley (ME) Dennis A. Lindner (MN) 0365. Their exemptions are effective as
The drivers were included in one of John Murray (WA) of April 27, 2016 and will expire on
the following dockets: Docket No. Michael Nichols (GA) April 27, 2018.
FMCSA–1999–5748; FMCSA–1999– Dino J. Pires (CT) In accordance with 49 U.S.C. 31315,
Anthony S. Poindexter (MD) each exemption will be valid for two
6156; FMCSA–1999–6480; FMCSA–
Phil N. Schad (MO) years from the effective date unless
2003–15892; FMCSA–2003–16564; Glen A. Schroeder (OR)
FMCSA–2005–22194; FMCSA–2005– revoked earlier by FMCSA. The
John B. Theres (IL) exemption will be revoked if the
23099; FMCSA–2005–23238; FMCSA– Robert S. Waltz (ME)
2006–23773; FMCSA–2009–0321. Their following occurs: (1) The person fails to
Willard H. Weerts (IL)
exemptions are effective as of April 14, comply with the terms and conditions
The drivers were included on the of the exemption; (2) the exemption has
2016 and will expire on April 14, 2018. following docket: Docket No. FMCSA–
As of April 16, 2016, and in resulted in a lower level of safety than
2014–0002. Their exemptions are was maintained prior to being granted;
accordance with 49 U.S.C. 31136(e) and
effective as of April 18, 2016 and will or (3) continuation of the exemption
31315, Glen A. Schroeder (SD), has
expire on April 18, 2018. would not be consistent with the goals
satisfied the conditions for obtaining a As of April 23, 2016, and in
renewed exemption from the vision and objectives of 49 U.S.C. 31136 and
accordance with 49 U.S.C. 31136(e) and 31315.
requirements (79 FR 10611; 79 FR 31315, the following 11 individuals
22003). have satisfied the conditions for Issued on: December 2, 2016.
This driver was included in the obtaining a renewed exemption from the Larry W. Minor,
following docket: Docket No. FMCSA– vision requirements (67 FR 10471; 67 Associate Administrator for Policy.
2014–0002. The exemption is effective FR 19798; 68 FR 61857; 68 FR 74699; [FR Doc. 2016–29832 Filed 12–12–16; 8:45 am]
as of April 16, 2016 and will expire on 68 FR 75715; 69 FR 19611; 71 FR 6825; BILLING CODE 4910–EX–P
April 16, 2018. 71 FR 6829; 71 FR 19604; 72 FR 46261;
As of April 17, 2016, and in 72 FR 54972; 72 FR 71993; 73 FR 15254;
accordance with 49 U.S.C. 31136(e) and 73 FR 16950; 74 FR 57553; 74 FR 65842; DEPARTMENT OF TRANSPORTATION
31315, the following 7 individuals have 75 FR 1835; 75 FR 9478; 75 FR 9482; 75
satisfied the conditions for obtaining a FR 20881; 77 FR 7657; 77 FR 10604; 77 Federal Motor Carrier Safety
renewed exemption from the vision FR 13689; 77 FR 17115; 77 FR 22059): Administration
requirements (77 FR 19749; 77 FR
22838; 79 FR 15794): Lyle H. Banser (WI) [Docket No. FMCSA–2016–0380]
Cary Carn (NJ)
Robert J. Abbas (MN) Charley J. Davis (OK) Qualification of Drivers; Exemption
Paul T. Browning (MT) Derek T. Ford (MD) Applications; Diabetes Mellitus
Kevan J. Larson (ID) Thomas R. Hedden (IL)
Gilbert M. Rosas (AZ) Earl R. Mark (IL) AGENCY: Federal Motor Carrier Safety
Kim A. Shaffer (PA) Richard K. Mell (VA) Administration (FMCSA).
Larry W. Slinker (VA) Douglas A. Mendoza (MD) ACTION: Notice of applications for
Lonnie J. Supanchick (NV) Russell L. Moyers, Sr. (WV) exemptions; request for comments.
The drivers were included in one of Danny Rolfe (ME)
Donald Schaeffer (MO) SUMMARY: FMCSA announces receipt of
the following dockets: Docket No.
applications from 43 individuals for
FMCSA–2011–0378. Their exemptions The drivers were included in one of
exemption from the prohibition against
are effective as of April 17, 2016 and the following dockets: Docket No.
persons with insulin-treated diabetes
will expire on April 17, 2018. FMCSA–2001–11426; FMCSA–2003–
mellitus (ITDM) operating commercial
As of April 18, 2016, and in 16241; FMCSA–2003–16564; FMCSA–
motor vehicles (CMVs) in interstate
accordance with 49 U.S.C. 31136(e) and 2007–0071; FMCSA–2007–28695;
commerce. If granted, the exemptions
31315, the following 27 individuals FMCSA–2009–0291; FMCSA–2009–
would enable these individuals with
have satisfied the conditions for 0321; FMCSA–2011–0324. Their
ITDM to operate CMVs in interstate
obtaining a renewed exemption from the exemptions are effective as of April 23,
commerce.
vision requirements (79 FR 10606; 79 2016 and will expire on April 23, 2018.
FR 10607; 79 FR 10608; 79 FR 10609; As of April 27, 2016, and in DATES: Comments must be received on
79 FR 10610; 79 FR 10611; 79 FR accordance with 49 U.S.C. 31136(e) and or before January 12, 2017.
22003): 31315, the following 9 individuals have ADDRESSES: You may submit comments
John M. Alfano (MI) satisfied the conditions for obtaining a bearing the Federal Docket Management
Felipe Bayron (WI) renewed exemption from the vision System (FDMS) Docket No. FMCSA–
Thomas Benavidez, Jr. (ID) requirements (75 FR 9480; 75 FR 22176; 2016–0380 using any of the following
Gary A. Budde (IL) 77 FR 3552; 77 FR 13691; 77 FR 17108; methods:
Mark Castleman (MN) 79 FR 17642; 79 FR 17643): • Federal eRulemaking Portal: Go to
Lorimer Christianson (IA) Chad L. Burnham (ME) http://www.regulations.gov. Follow the
David L. Dykes (FL) Loren D. Chapman (MN) on-line instructions for submitting
Daniel Fedder (IL) David A. Christenson (NV) comments.
• Mail: Docket Management Facility;
pmangrum on DSK3GDR082PROD with NOTICES
Edward A. Flitton (UT) John T. Edmondson (AL)
Juan Gallo-Gomez (CT) Paul K. Leger (NH) U.S. Department of Transportation, 1200
Andeberhan O. Gidey (WA) Martin L. Reyes (IL) New Jersey Avenue SE., West Building
Luis Gomez-Banda (NV) Gerald L. Rush, Jr. (NJ) Ground Floor, Room W12–140,
Christopher Goodwin (NC) Alan T. Watterson (MA) Washington, DC 20590–0001.
David Knobloch (MI) Larry W. Winkler (MO) • Hand Delivery: West Building
Gregory L. Kockelman (MN) The drivers were included in one of Ground Floor, Room W12–140, 1200
Mark La Fleur (MD) the following dockets: Docket No. New Jersey Avenue SE., Washington,
VerDate Sep<11>2014 15:08 Dec 12, 2016 Jkt 241001 PO 00000 Frm 00163 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1](https://thefederalregister.org/doc/81_FR_90293/page/1.svg)
![90060 Federal Register / Vol. 81, No. 239 / Tuesday, December 13, 2016 / Notices
examined him in 2016 and certified that requirements of the vision standard at Federal Register on November 8, 2005
he does not have diabetic retinopathy. 49 CFR 391.41(b)(10). His optometrist (70 FR 67777), remain in effect.
He holds an operator’s license from examined him in 2016 and certified that
IV. Submitting Comments
Pennsylvania. he does not have diabetic retinopathy.
He holds an operator’s license from You may submit your comments and
Jared M. Wabeke material online or by fax, mail, or hand
Minnesota.
Mr. Wabeke, 30, has had ITDM since delivery, but please use only one of
2013. His endocrinologist examined him III. Request for Comments these means. FMCSA recommends that
in 2016 and certified that he has had no In accordance with 49 U.S.C. 31136(e) you include your name and a mailing
severe hypoglycemic reactions resulting and 31315, FMCSA requests public address, an email address, or a phone
in loss of consciousness, requiring the comment from all interested persons on number in the body of your document
assistance of another person, or the exemption petitions described in so that FMCSA can contact you if there
resulting in impaired cognitive function this notice. We will consider all are questions regarding your
that occurred without warning in the comments received before the close of submission.
past 12 months and no recurrent (2 or business on the closing date indicated To submit your comment online, go to
more) severe hypoglycemic episodes in in the date section of the notice. http://www.regulations.gov and in the
the last 5 years. His endocrinologist FMCSA notes that section 4129 of the search box insert the docket number
certifies that Mr. Wabeke understands Safe, Accountable, Flexible and FMCSA–2016–0380 and click the search
diabetes management and monitoring, Efficient Transportation Equity Act: A button. When the new screen appears,
has stable control of his diabetes using Legacy for Users requires the Secretary click on the blue ‘‘Comment Now!’’
insulin, and is able to drive a CMV to revise its diabetes exemption program button on the right hand side of the
safely. Mr. Wabeke meets the established on September 3, 2003 (68 FR page. On the new page, enter
requirements of the vision standard at 52441).1 The revision must provide for information required including the
49 CFR 391.41(b)(10). His optometrist individual assessment of drivers with specific section of this document to
examined him in 2016 and certified that diabetes mellitus, and be consistent which each comment applies, and
he does not have diabetic retinopathy. with the criteria described in section provide a reason for each suggestion or
He holds a CDL from Michigan. 4018 of the Transportation Equity Act recommendation. If you submit your
Marcus D. Wade for the 21st Century (49 U.S.C. 31305). comments by mail or hand delivery,
Section 4129 requires: (1) Elimination submit them in an unbound format, no
Mr. Wade, 22, has had ITDM since
of the requirement for 3 years of larger than 81⁄2 by 11 inches, suitable for
2013. His endocrinologist examined him
experience operating CMVs while being copying and electronic filing. If you
in 2016 and certified that he has had no
treated with insulin; and (2) submit comments by mail and would
severe hypoglycemic reactions resulting
establishment of a specified minimum like to know that they reached the
in loss of consciousness, requiring the
period of insulin use to demonstrate facility, please enclose a stamped, self-
assistance of another person, or
stable control of diabetes before being addressed postcard or envelope.
resulting in impaired cognitive function
allowed to operate a CMV. We will consider all comments and
that occurred without warning in the
In response to section 4129, FMCSA material received during the comment
past 12 months and no recurrent (2 or
made immediate revisions to the period. FMCSA may issue a final
more) severe hypoglycemic episodes in
diabetes exemption program established determination at any time after the close
the last 5 years. His endocrinologist
by the September 3, 2003 notice. of the comment period.
certifies that Mr. Wade understands
FMCSA discontinued use of the 3-year
diabetes management and monitoring, V. Viewing Comments and Documents
driving experience and fulfilled the
has stable control of his diabetes using To view comments, as well as any
requirements of section 4129 while
insulin, and is able to drive a CMV documents mentioned in this preamble,
continuing to ensure that operation of
safely. Mr. Wade meets the go to http://www.regulations.gov and in
CMVs by drivers with ITDM will
requirements of the vision standard at the search box insert the docket number
achieve the requisite level of safety
49 CFR 391.41(b)(10). His optometrist FMCSA–2016–0380 and click ‘‘Search.’’
required of all exemptions granted
examined him in 2016 and certified that Next, click ‘‘Open Docket Folder’’ and
under 49 U.S.C.. 31136(e).
he does not have diabetic retinopathy. you will find all documents and
Section 4129(d) also directed FMCSA
He holds an operator’s license from comments related to this notice.
to ensure that drivers of CMVs with
Illinois.
ITDM are not held to a higher standard Issued on: December 2, 2016.
Tanner R. Walsh than other drivers, with the exception of Larry W. Minor,
Mr. Walsh, 22, has had ITDM since limited operating, monitoring and Associate Administrator for Policy.
2014. His endocrinologist examined him medical requirements that are deemed
[FR Doc. 2016–29825 Filed 12–12–16; 8:45 am]
in 2016 and certified that he has had no medically necessary.
BILLING CODE 4910–EX–P
severe hypoglycemic reactions resulting The FMCSA concluded that all of the
in loss of consciousness, requiring the operating, monitoring and medical
assistance of another person, or requirements set out in the September 3, DEPARTMENT OF TRANSPORTATION
resulting in impaired cognitive function 2003 notice, except as modified, were in
that occurred without warning in the compliance with section 4129(d). Maritime Administration
Therefore, all of the requirements set
pmangrum on DSK3GDR082PROD with NOTICES
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in out in the September 3, 2003 notice, [Docket Number MARAD–2016–0126]
the last 5 years. His endocrinologist except as modified by the notice in the
Waiver Request for Aquaculture
certifies that Mr. Walsh understands Support Operations for the 2017
1 Section 4129(a) refers to the 2003 notice as a
diabetes management and monitoring, Calendar Year: M/V COLBY PERCE and
‘‘final rule.’’ However, the 2003 notice did not issue
has stable control of his diabetes using a ‘‘final rule’’ but did establish the procedures and M/V RONJA CARRIER
insulin, and is able to drive a CMV standards for issuing exemptions for drivers with
safely. Mr. Walsh meets the ITDM. AGENCY: Maritime Administration, DOT.
VerDate Sep<11>2014 15:08 Dec 12, 2016 Jkt 241001 PO 00000 Frm 00169 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1](https://thefederalregister.org/doc/81_FR_90293/page/7.svg)
Document Created: 2016-12-13 02:44:25
Document Modified: 2016-12-13 02:44:25
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemptions; request for comments. | |
| Dates | Comments must be received on or before January 12, 2017. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. | |
| FR Citation | 81 FR 90054 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR